| Aktientyp | Stammaktie |
Merger mit Metuchen Pharmaceuticals
https://endpts.com/obliterated-by-alzheimers-failure-neurotrope-relinquishes-its-nasdaq-spot-in-reverse-merger/
https://seekingalpha.com/news/3533493-neurotrope-jumps-113-on-positive-data-on-lead-drug
Prüfung strategischer Alternativen
https://neurotrope.com/neurotrope-announces-review-of-strategic-alternatives-to-maximize-shareholder-value/